BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11736917)

  • 1. Hair loss after terbinafine treatment.
    Richert B; Uhoda I; De la Brassinne M
    Br J Dermatol; 2001 Nov; 145(5):842. PubMed ID: 11736917
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
    Ornstein DL; Ely P
    J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of systemic lupus erythematosus induced by terbinafine.
    Holmes S; Kemmett D
    Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
    Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
    Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe neutropenia associated with oral terbinafine therapy.
    Gupta AK; Soori GS; Del Rosso JQ; Bartos PB; Shear NH
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):765-7. PubMed ID: 9591825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glossopyrosis and terbinafine].
    Haneke E
    Dtsch Med Wochenschr; 1999 Oct; 124(40):1186. PubMed ID: 10548951
    [No Abstract]   [Full Text] [Related]  

  • 9. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis.
    Dominicus R; Weidner C; Tate H; Kroon HA
    Br J Dermatol; 2012 Jun; 166(6):1360-2. PubMed ID: 22136723
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral terbinafine treatment for toenail onychomycosis.
    De Berker D
    Br J Dermatol; 2001 May; 144(5):1098-9. PubMed ID: 11359413
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of superficial white onychomycosis with topical terbinafine cream.
    Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Sep; 141(3):604-5. PubMed ID: 10583101
    [No Abstract]   [Full Text] [Related]  

  • 16. Companies go toe to toe, as topical treatments for nail fungus bloom.
    Willyard C
    Nat Med; 2013 Jul; 19(7):794-5. PubMed ID: 23836202
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral terbinafine-induced plantar pustular psoriasis].
    Le Guyadec T; Saint-Blancard P; Bosonnet S; Le Vagueresse R; Lanternier G
    Ann Dermatol Venereol; 2000 Mar; 127(3):279-81. PubMed ID: 10804301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse psoriasis induced by terbinafine.
    Pauluzzi P; Boccucci N
    Acta Derm Venereol; 1999 Sep; 79(5):389. PubMed ID: 10494721
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
    Goodfield MJ
    Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.